-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
Abcam plc (NASDAQ:ABCM – Get Rating) saw strong trading volume on Monday . 4,040 shares were traded during mid-day trading, a decline of 98% from the previous session's volume of 162,655 shares.The stock last traded at $15.12 and had previously closed at $14.62.
Wall Street Analysts Forecast Growth
Separately, Panmure Gordon upgraded Abcam from a "hold" rating to a "buy" rating in a report on Monday, September 5th.
Get Abcam alerts:Abcam Stock Up 0.1 %
The stock has a 50 day simple moving average of $14.82 and a two-hundred day simple moving average of $15.54.
Institutional Trading of Abcam
A number of hedge funds and other institutional investors have recently bought and sold shares of ABCM. HM Payson & Co. acquired a new stake in Abcam in the fourth quarter valued at $29,000. 1832 Asset Management L.P. acquired a new stake in Abcam in the first quarter valued at $32,000. National Bank of Canada FI increased its position in shares of Abcam by 71.3% during the second quarter. National Bank of Canada FI now owns 2,777 shares of the company's stock worth $40,000 after purchasing an additional 1,156 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Abcam by 48.7% during the first quarter. JPMorgan Chase & Co. now owns 3,044 shares of the company's stock worth $56,000 after purchasing an additional 997 shares in the last quarter. Finally, Advisor Group Holdings Inc. increased its position in shares of Abcam by 20.5% during the fourth quarter. Advisor Group Holdings Inc. now owns 5,876 shares of the company's stock worth $138,000 after purchasing an additional 999 shares in the last quarter. 11.82% of the stock is currently owned by institutional investors and hedge funds.Abcam Company Profile
(Get Rating)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Read More
- Get a free copy of the StockNews.com research report on Abcam (ABCM)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
Abcam plc (NASDAQ:ABCM – Get Rating) saw strong trading volume on Monday . 4,040 shares were traded during mid-day trading, a decline of 98% from the previous session's volume of 162,655 shares.The stock last traded at $15.12 and had previously closed at $14.62.
周一，阿布卡姆公司(纳斯达克代码：ABCM-GET Rating)的成交量强劲。午盘成交量为4,040股，较前一交易日的162,655股减少98%。该股尾盘报15.12美元，此前收盘报14.62美元。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Separately, Panmure Gordon upgraded Abcam from a "hold" rating to a "buy" rating in a report on Monday, September 5th.
另外，Panmure Gordon在9月5日周一的一份报告中将Abcam的评级从持有上调至买入。
Abcam Stock Up 0.1 %
Abcam股价上涨0.1%
The stock has a 50 day simple moving average of $14.82 and a two-hundred day simple moving average of $15.54.
该股的50日简单移动均线切入位为14.82美元，200日简单移动均线切入位为15.54美元。
Institutional Trading of Abcam
ABCAM的机构性交易
Abcam Company Profile
Abcam公司简介
(Get Rating)
(获取评级)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Abcam plc是一家生命科学公司，专注于识别、开发和分发用于科学研究、诊断和药物发现的试剂和工具。它的主要产品包括一抗和二抗；结合抗体和结合试剂盒；单链和多重免疫分析；包括细胞因子的蛋白质和多肽；编辑的细胞系和裂解产物；以及各种其他产品，包括细胞活动试剂盒、miRNA试剂盒、生物化学品和细胞信号途径工具。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Abcam (ABCM)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 免费获取关于abcam(ABCM)的StockNews.com研究报告
- 这三份报告将告诉我们许多关于当前经济的情况。
- 下面的五个是不是打得太高了？
- 这就是现在对标准普尔500指数的预期
- 关于甲骨文的FQ1报告，你需要知道的两件事
- 波动市场的三只价值股
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
接收abcam日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Abcam和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧